2019 annual financial data

Intellia Therapeutics 2019 Net margin

Direct answer

Net margin was -230.92%.

Operating income was -106,368,000 USD and net income was -99,533,000 USD.
Operating cash flow was -103,240,000 USD.

Get free Intellia Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
43,103,000 USD
Operating income
-106,368,000 USD
Net income
-99,533,000 USD
Operating cash flow
-103,240,000 USD